{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T11:37:49Z","timestamp":1781005069995,"version":"3.54.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1124\/mol.110.067066","type":"journal-article","created":{"date-parts":[[2010,9,21]],"date-time":"2010-09-21T02:22:48Z","timestamp":1285035768000},"page":"983-992","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Functional Selectivity in Adrenergic and Angiotensin Signaling Systems"],"prefix":"10.1016","volume":"78","author":[{"given":"Chetan B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabila","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A.","family":"Rockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.110.067066_bib1","doi-asserted-by":"crossref","first-page":"8855","DOI":"10.1074\/jbc.M808463200","article-title":"{beta}-Arrestin-2 mediates anti-apoptotic signaling through regulation of BAD phosphorylation","volume":"284","author":"Ahn","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib2","doi-asserted-by":"crossref","first-page":"35518","DOI":"10.1074\/jbc.M405878200","article-title":"Differential kinetic and spatial patterns of beta-arrestin and G protein-mediated ERK activation by the angiotensin II receptor","volume":"279","author":"Ahn","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib3","doi-asserted-by":"crossref","first-page":"H1427","DOI":"10.1152\/ajpheart.00908.2005","article-title":"Myocardial beta1-adrenergic receptor polymorphisms affect functional recovery after ischemic injury","volume":"290","author":"Akhter","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/mol.110.067066_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/ncb1005","article-title":"Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK","volume":"5","author":"Allan","year":"2003","journal-title":"Nat Cell Biol"},{"key":"10.1124\/mol.110.067066_bib5","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0735-1097(96)00535-9","article-title":"The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction","volume":"29","author":"Amant","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.110.067066_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1742-7843.2007.00063.x","article-title":"The angiotensin type 1 receptor activates extracellular signal-regulated kinases 1 and 2 by G protein-dependent and -independent pathways in cardiac myocytes and langendorff-perfused hearts","volume":"100","author":"Aplin","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1124\/mol.110.067066_bib7","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1124\/mol.64.6.1357","article-title":"Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling","volume":"64","author":"Baker","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067066_bib8","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1124\/mol.110.067066_bib9","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/sj.embor.7400373","article-title":"Monitoring agonist-promoted conformational changes of beta-arrestin in living cells by intramolecular BRET","volume":"6","author":"Charest","year":"2005","journal-title":"EMBO Rep"},{"key":"10.1124\/mol.110.067066_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1074\/mcp.M900550-MCP200","article-title":"Quantitative phosphoproteomics dissection of seven-transmembrane receptor signaling using full and biased agonists","volume":"9","author":"Christensen","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1124\/mol.110.067066_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/36362","article-title":"Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A","volume":"390","author":"Daaka","year":"1997","journal-title":"Nature"},{"key":"10.1124\/mol.110.067066_bib12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0140-6736(02)08089-3","article-title":"Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Dahl\u00f6f","year":"2002","journal-title":"Lancet"},{"key":"10.1124\/mol.110.067066_bib13","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1345\/aph.1K657","article-title":"Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan","volume":"42","author":"de Denus","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1124\/mol.110.067066_bib14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev.physiol.69.022405.154749","article-title":"Beta-arrestins and cell signaling","volume":"69","author":"DeWire","year":"2007","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/mol.110.067066_bib15","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.1074\/jbc.M708118200","article-title":"beta-arrestin-biased agonism at the beta2-adrenergic receptor","volume":"283","author":"Drake","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib16","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1210\/en.2002-0135","article-title":"The role of a conserved region of the second intracellular loop in AT1 angiotensin receptor activation and signaling","volume":"144","author":"G\u00e1borik","year":"2003","journal-title":"Endocrinology"},{"key":"10.1124\/mol.110.067066_bib17","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1124\/mol.106.026716","article-title":"Distinct signaling profiles of beta1 and beta2 adrenergic receptor ligands toward adenylyl cyclase and mitogen-activated protein kinase reveals the pluridimensionality of efficacy","volume":"70","author":"Galandrin","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067066_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2007.06.005","article-title":"The evasive nature of drug efficacy: implications for drug discovery","volume":"28","author":"Galandrin","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.110.067066_bib19","doi-asserted-by":"crossref","first-page":"24433","DOI":"10.1074\/jbc.C100162200","article-title":"Functionally different agonists induce distinct conformations in the G protein coupling domain of the beta 2 adrenergic receptor","volume":"276","author":"Ghanouni","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib20","doi-asserted-by":"crossref","first-page":"13895","DOI":"10.1074\/jbc.M611904200","article-title":"Structure and conformational changes in the C-terminal domain of the beta2-adrenoceptor: insights from fluorescence resonance energy transfer studies","volume":"282","author":"Granier","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/35002111","article-title":"Regulation of carbamoyl phosphate synthetase by MAP kinase","volume":"403","author":"Graves","year":"2000","journal-title":"Nature"},{"key":"10.1124\/mol.110.067066_bib22","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jama.283.10.1295","article-title":"Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR\/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group","volume":"283","author":"Hjalmarson","year":"2000","journal-title":"JAMA"},{"key":"10.1124\/mol.110.067066_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/sj.onc.1202183","article-title":"Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the road to death","volume":"17","author":"Jarpe","year":"1998","journal-title":"Oncogene"},{"key":"10.1124\/mol.110.067066_bib24","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1096\/fj.00-0438rev","article-title":"Inverse, protean, and ligand-selective agonism: matters of receptor conformation","volume":"15","author":"Kenakin","year":"2001","journal-title":"FASEB J"},{"key":"10.1124\/mol.110.067066_bib25","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0165-6147(03)00167-6","article-title":"Ligand-selective receptor conformations revisited: the promise and the problem","volume":"24","author":"Kenakin","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.110.067066_bib26","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2004.02.012","article-title":"Principles: receptor theory in pharmacology","volume":"25","author":"Kenakin","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.110.067066_bib27","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrd1875","article-title":"New concepts in drug discovery: collateral efficacy and permissive antagonism","volume":"4","author":"Kenakin","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.110.067066_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1124\/pr.108.000992","article-title":"Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery","volume":"62","author":"Kenakin","year":"2010","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.110.067066_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.tips.2009.06.007","article-title":"\u20327TM receptor allostery: putting numbers to shapeshifting proteins","volume":"30","author":"Kenakin","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/mol.110.067066_bib30","doi-asserted-by":"crossref","first-page":"14555","DOI":"10.1073\/pnas.0804745105","article-title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation","volume":"105","author":"Kim","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib31","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1074\/jbc.M808176200","article-title":"Independent beta-arrestin2 and Gq\/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor","volume":"284","author":"Kim","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib32","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1073\/pnas.0409532102","article-title":"Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling","volume":"102","author":"Kim","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib33","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.294.12.1526","article-title":"Beta2-adrenergic receptor genotype and survival among patients receiving beta-blocker therapy after an acute coronary syndrome","volume":"294","author":"Lanfear","year":"2005","journal-title":"JAMA"},{"key":"10.1124\/mol.110.067066_bib34","doi-asserted-by":"crossref","first-page":"18677","DOI":"10.1074\/jbc.273.30.18677","article-title":"G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization","volume":"273","author":"Lefkowitz","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib35","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1126\/science.1109237","article-title":"Transduction of receptor signals by beta-arrestins","volume":"308","author":"Lefkowitz","year":"2005","journal-title":"Science"},{"key":"10.1124\/mol.110.067066_bib36","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/nm1750","article-title":"A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure","volume":"14","author":"Liggett","year":"2008","journal-title":"Nat Med"},{"key":"10.1124\/mol.110.067066_bib37","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1038\/sj.onc.1206792","article-title":"Phosphorylation of Bim-EL by Erk1\/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function","volume":"22","author":"Luciano","year":"2003","journal-title":"Oncogene"},{"key":"10.1124\/mol.110.067066_bib38","doi-asserted-by":"crossref","first-page":"19443","DOI":"10.1074\/jbc.271.32.19443","article-title":"Role of c-Src tyrosine kinase in G protein-coupled receptor- and Gbetagamma subunit-mediated activation of mitogen-activated protein kinases","volume":"271","author":"Luttrell","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1083\/jcb.200911047","article-title":"beta-Arrestin-dependent activation of Ca(2+)\/calmodulin kinase II after beta(1)-adrenergic receptor stimulation","volume":"189","author":"Mangmool","year":"2010","journal-title":"J Cell Biol"},{"key":"10.1124\/mol.110.067066_bib40","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.cellsig.2004.05.002","article-title":"PKA-mediated phosphorylation of the beta1-adrenergic receptor promotes Gs\/Gi switching","volume":"16","author":"Martin","year":"2004","journal-title":"Cell Signal"},{"key":"10.1124\/mol.110.067066_bib41","doi-asserted-by":"crossref","first-page":"9572","DOI":"10.1074\/jbc.275.13.9572","article-title":"The beta(2)-adrenergic receptor mediates extracellular signal-regulated kinase activation via assembly of a multi-receptor complex with the epidermal growth factor receptor","volume":"275","author":"Maudsley","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib42","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1038\/sj.onc.1210394","article-title":"Integrating signals from RTKs to ERK\/MAPK","volume":"26","author":"McKay","year":"2007","journal-title":"Oncogene"},{"key":"10.1124\/mol.110.067066_bib43","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/nm930","article-title":"Beta 1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure","volume":"9","author":"Mialet Perez","year":"2003","journal-title":"Nat Med"},{"key":"10.1124\/mol.110.067066_bib44","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1172\/JCI31901","article-title":"Beta-arrestin-mediated beta1-adrenergic receptor transactivation of the EGFR confers cardioprotection","volume":"117","author":"Noma","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.110.067066_bib45","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1161\/01.CIR.0000035653.72855.BF","article-title":"Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1124\/mol.110.067066_bib46","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1073\/pnas.97.4.1489","article-title":"Role of endocytosis in the activation of the extracellular signal-regulated kinase cascade by sequestering and nonsequestering G protein-coupled receptors","volume":"97","author":"Pierce","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib47","doi-asserted-by":"crossref","first-page":"16284","DOI":"10.1073\/pnas.0607583103","article-title":"Beta-arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes","volume":"103","author":"Rajagopal","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib48","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","article-title":"Teaching old receptors new tricks: biasing seven-transmembrane receptors","volume":"9","author":"Rajagopal","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/mol.110.067066_bib49","doi-asserted-by":"crossref","first-page":"ra46","DOI":"10.1126\/scisignal.2000769","article-title":"beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress","volume":"3","author":"Rakesh","year":"2010","journal-title":"Sci Signal"},{"key":"10.1124\/mol.110.067066_bib50","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1172\/JCI30012","article-title":"Real-time optical recording of beta1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol","volume":"117","author":"Rochais","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.110.067066_bib51","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/415206a","article-title":"Seven-transmembrane-spanning receptors and heart function","volume":"415","author":"Rockman","year":"2002","journal-title":"Nature"},{"key":"10.1124\/mol.110.067066_bib52","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jcp.21246","article-title":"Mitogenic signaling pathways induced by G protein-coupled receptors","volume":"213","author":"Rozengurt","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1124\/mol.110.067066_bib53","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jacc.2008.05.022","article-title":"Lack of association between adrenergic receptor genotypes and survival in heart failure patients treated with carvedilol or metoprolol","volume":"52","author":"Sehnert","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1124\/mol.110.067066_bib54","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1074\/jbc.M506576200","article-title":"beta-arrestin-dependent, G protein-independent ERK1\/2 activation by the beta2 adrenergic receptor","volume":"281","author":"Shenoy","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib55","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.amjcard.2006.08.020","article-title":"Relation of beta(2)-adrenoceptor haplotype to risk of death and heart transplantation in patients with heart failure","volume":"99","author":"Shin","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1124\/mol.110.067066_bib56","doi-asserted-by":"crossref","first-page":"9988","DOI":"10.1073\/pnas.0804246105","article-title":"Distinct conformational changes in beta-arrestin report biased agonism at seven-transmembrane receptors","volume":"105","author":"Shukla","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib57","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1161\/01.HYP.36.3.411","article-title":"Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet","volume":"36","author":"Spiering","year":"2000","journal-title":"Hypertension"},{"key":"10.1124\/mol.110.067066_bib58","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.molcel.2006.01.023","article-title":"Growth factor signaling regulates elongation of RNA polymerase I transcription in mammals via UBF phosphorylation and r-chromatin remodeling","volume":"21","author":"Stefanovsky","year":"2006","journal-title":"Mol Cell"},{"key":"10.1124\/mol.110.067066_bib59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1124\/mol.109.061440","article-title":"Genetic deletion of p90 ribosomal S6 kinase 2 alters patterns of 5-hydroxytryptamine 2A serotonin receptor functional selectivity","volume":"77","author":"Strachan","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.110.067066_bib60","doi-asserted-by":"crossref","first-page":"6258","DOI":"10.1074\/jbc.M212231200","article-title":"The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation","volume":"278","author":"Tohgo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104463","article-title":"Functional selectivity and classical concepts of quantitative pharmacology","volume":"320","author":"Urban","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.110.067066_bib62","doi-asserted-by":"crossref","first-page":"20577","DOI":"10.1074\/jbc.M513605200","article-title":"G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer","volume":"281","author":"Violin","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.110.067066_bib63","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1093\/emboj\/16.8.1909","article-title":"Mitogen-activated protein kinases activate the serine\/threonine kinases Mnk1 and Mnk2","volume":"16","author":"Waskiewicz","year":"1997","journal-title":"EMBO J"},{"key":"10.1124\/mol.110.067066_bib64","doi-asserted-by":"crossref","first-page":"10782","DOI":"10.1073\/pnas.1834556100","article-title":"Independent beta-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2","volume":"100","author":"Wei","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib65","doi-asserted-by":"crossref","first-page":"16657","DOI":"10.1073\/pnas.0707936104","article-title":"A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling","volume":"104","author":"Wisler","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib66","doi-asserted-by":"crossref","first-page":"12011","DOI":"10.1073\/pnas.0704849104","article-title":"Functional specialization of beta-arrestin interactions revealed by proteomic analysis","volume":"104","author":"Xiao","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib67","doi-asserted-by":"crossref","first-page":"15299","DOI":"10.1073\/pnas.1008461107","article-title":"Global phosphorylation analysis of beta-arrestin-mediated signaling downstream of a seven transmembrane receptor (7TMR)","volume":"107","author":"Xiao","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib68","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1172\/JCI25330","article-title":"Cardiac-specific overexpression of AT1 receptor mutant lacking G alpha q\/G alpha i coupling causes hypertrophy and bradycardia in transgenic mice","volume":"115","author":"Zhai","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1124\/mol.110.067066_bib69","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1073\/pnas.98.4.1607","article-title":"Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes","volume":"98","author":"Zhu","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/mol.110.067066_bib70","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/01.RES.82.3.337","article-title":"Cell type-specific angiotensin II-evoked signal transduction pathways: critical roles of Gbetagamma subunit, Src family, and Ras in cardiac fibroblasts","volume":"82","author":"Zou","year":"1998","journal-title":"Circ Res"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24028335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.110.067066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T09:48:59Z","timestamp":1739958539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24028335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":70,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0026895X24028335"],"URL":"https:\/\/doi.org\/10.1124\/mol.110.067066","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functional Selectivity in Adrenergic and Angiotensin Signaling Systems","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.110.067066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}